22nd Century Group Inc. develops and commercializes reduced-nicotine tobacco products built on proprietary plant biotechnology. Its VLN® combustible cigarette products use low-nicotine tobacco and are described in company materials as FDA-authorized reduced nicotine cigarettes in the United States. Company updates commonly address VLN retail distribution, state authorizations, PMTA-related product expansion, licensing strategy, tobacco-variety research and engagement with FDA and public-health stakeholders.
News also covers operating results for the tobacco business, including branded VLN products, contract manufacturing volumes, filtered cigars and other distributed tobacco products. Recent company reporting frames results around commercial expansion, cost management, higher-margin branded products and the completed exit from the hemp/cannabis business.
22nd Century Group (Nasdaq: XXII) has announced a significant financial milestone by becoming debt-free after repaying its remaining $3.9 million senior secured debt following the completion of its Series A convertible preferred stock offering. The company has eliminated over $20 million in senior secured and subordinated debt under CEO Larry Firestone's leadership.
The financial restructuring has resulted in an approximate $9.1 million increase in adjusted pro forma net tangible book value ($1.05 per share). The company plans to utilize its capital to expand its very low nicotine tobacco leaf inventory in Q4 2025, with capacity to produce over 1 million cartons of VLN combustible products. The company's VLN® cigarettes, containing 95% less nicotine than traditional cigarettes, remain the only FDA-authorized low nicotine combustible cigarette in the United States.
22nd Century Group (Nasdaq: XXII), a tobacco products company focused on reducing smoking harms and nicotine addiction, has announced its participation in the upcoming HC Wainwright Conference. The company's leadership, including CEO Larry Firestone and CFO Dan Otto, will conduct investor meetings on September 9, 2025 at the Lotte New York Palace Hotel.
Interested investors can schedule meetings through their HC Wainwright representative or by contacting 22nd Century's Investor Relations directly.
22nd Century Group (Nasdaq: XXII) CEO Larry Firestone provided a comprehensive update on the company's VLN® reduced nicotine tobacco products and regulatory developments. The company announced two major partnerships with Smoker Friendly and Pinnacle for VLN® product distribution, with initial Pinnacle stocking orders shipped in August 2025.
The FDA's proposed Tobacco Product Standard for Nicotine Yield, expected by September 15, 2025, could mandate a 0.7mg/g maximum nicotine content. The company is expanding its VLN® product line to include 100mm cigarettes, international versions, and filtered cigars. Additionally, research is underway exploring potential links between their non-GMO low nicotine tobacco genetics and reduced levels of harmful TSNAs (Tobacco-Specific Nitrosamines).
22nd Century Group (Nasdaq: XXII), a tobacco products company focused on reducing smoking harms through nicotine addiction control, has announced its participation in the upcoming Emerging Growth Virtual Investor Conference.
CEO Larry Firestone and CFO Dan Otto will present on August 20, 2025 at 1:10 PM ET. Investors can register online to attend the virtual presentation and submit questions in advance. A replay will be available in the Events section of the company's IR website.
22nd Century Group (Nasdaq: XXII) reported Q2 2025 financial results, showing a revenue decline to $4.1 million from $6.0 million in Q1 2025. The company reported a net loss of $3.3 million and an Adjusted EBITDA loss of $2.6 million.
Key developments include expanded state authorizations for VLN® products (now in 44 states), partnership with Pinnacle for VLN® distribution in nearly 1,000 locations of a top-5 c-store chain, and debt reduction of $1.0 million to $3.8 million. The company's cigarette volumes increased to 594,000 cartons in Q2 2025 compared to 319,000 in Q1 2025.
The company is advancing its tobacco harm reduction strategy with its proprietary reduced nicotine content tobacco products, including development of a 100mm VLN® cigarette prototype targeting FDA submission in Q4 2025.
[ "Expanded state authorizations to 44 states for VLN® products", "Secured partnership with Pinnacle VLN® for distribution in nearly 1,000 top-5 c-store locations", "Increased cigarette carton volumes by 86% quarter-over-quarter to 594,000", "Reduced debt by $1.0 million to $3.8 million", "Advanced development of 100mm VLN® reduced nicotine cigarette prototype" ]22nd Century Group (Nasdaq: XXII) has scheduled its Second Quarter 2025 earnings conference call for August 14, 2025, at 8:00 AM ET. The company will release its financial results via press release at 6:00 AM ET the same day.
CEO Larry Firestone and CFO Dan Otto will lead the webcast, discussing quarterly results, recent developments, and outlook for 2025. The webcast will be available live and archived on the company's investor relations website.
22nd Century Group (Nasdaq: XXII) announced the initial shipments of its Pinnacle VLN® Gold and Pinnacle VLN® Menthol reduced nicotine cigarettes. The products will launch on September 1, 2025 across nearly 1,000 locations in 12 states through a top-5 U.S. convenience store chain.
The Pinnacle VLN® cigarettes contain 95% less nicotine compared to traditional cigarettes, meeting the FDA's proposed standard of less than 0.7 mg/g nicotine content. These products are the first and only FDA-authorized combusted cigarettes specifically designed to reduce nicotine intake, supported by extensive clinical research demonstrating their effectiveness in reducing smoking habits.
22nd Century Group (Nasdaq: XXII) welcomes the American Academy of Family Physicians' (AAFP) support for the FDA's proposed reduced nicotine mandate. The AAFP, representing over 128,300 family physicians, endorses establishing a maximum nicotine yield of 0.7 milligrams per gram of tobacco in combustible products.
The company's VLN® products, including partner brands Smoker Friendly VLN® and Pinnacle VLN®, are currently the only FDA-authorized reduced nicotine content cigarettes that comply with the proposed standard. According to the release, smoking causes over 480,000 deaths and costs more than $600 billion annually in the United States, while reducing life expectancy by 10 years.
22nd Century Group (Nasdaq: XXII) announced significant progress in state authorizations for its tobacco product portfolio. The company has secured approval to sell its VLN® reduced nicotine content cigarettes in up to 41 states, along with expanded authorizations for partner brands and conventional products.
The company's flagship VLN® products contain 95% less nicotine than conventional cigarettes and are the only combustible cigarettes that comply with the FDA's proposed Low Nicotine Mandate. 22nd Century has secured partnerships with retailers representing over 2,000 outlets for implementation in the second half of 2025.
The expanded state authorizations cover multiple product lines including VLN® Gold and Green (41 states), VLN® Red (21 states), Smoker Friendly VLN® (20 states), Pinnacle® VLN® (20 states), and various conventional products across different states.
22nd Century Group (Nasdaq: XXII) is gaining traction with its VLN® reduced nicotine content cigarettes as multiple tobacco brands partner to expand product availability. The company's proprietary tobacco contains 95% less nicotine than conventional cigarettes, meeting the FDA's proposed standard of 0.7 mg nicotine per gram of tobacco.
The FDA's January 2025 proposed Tobacco Product Standard aims to reduce smoking-related harm by limiting nicotine content in cigarettes. VLN® products, averaging 0.5 mg per gram, are currently the only FDA-authorized combustible cigarettes meeting this standard. The FDA projects this initiative could prevent approximately 48 million youth and young adults from starting smoking by 2100.
New partnerships including Smoker Friendly VLN® and Pinnacle VLN® demonstrate growing industry adoption ahead of the standard's implementation, expected two years after final approval.